Johanson R., Newburn M., Macfarlane A. Has the medicalisation of childbirth gone too far?
// BMJ. 2002. Vol. 324. № 7342. P. 892–895.Kaunitz A. M., Spence C., Danielson T. S., Rochat R. W., Grimes D. A. Perinatal and maternal mortality in a religious group avoiding obstetric care
// American Journal of Obstetrics & Gynecology. 1984. December 1. Vol. 150. № 7. P. 826–831.Stamatakis E., Weiler R., Ioannidis J. P. Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review
// European journal of clinical investigation. 2013. Vol. 43. № 5. P. 469–475.Moynihan R., Doran E., Henry D. Disease mongering is now part of the global health debate
// PLoS Medicine. 2008. Vol. 5. № 5, e106.Simons J. The $
10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering drug, has become the bestselling pharmaceutical in history. Here’s how Pfizer did it // Fortune. 2003. January 20. Vol. 147. № 1. P. 58–62.Лечение ОРВИ и гриппа в рутинной клинической практике
// Фармацевтический вестник. 2017. 28 июля.Мизерницкий Ю. Л. Применение инновационного отечественного индуктора интерферона для профилактики и лечения острых респираторных вирусных инфекций у детей
// Медицинский совет. 2016. № 1. С. 50–53.Харламова Ф. С., Кладова О. В., Сергеева Э. М. и др. Клиническая эффективность препарата Кагоцел® при гриппе и ОРВИ у детей с
2 до 6 лет // Детские инфекции. 2010. № 4. С. 34–41.Вартанян Р. В., Сергеева Э. М., Чешик С. Г. Оценка терапевтической эффективности препарата Кагоцел® у детей младшего и дошкольного возраста с острыми респираторными вирусными инфекциями
// Детские инфекции. 2011. № 1. С. 36–41.Hill K. P., Ross J. S., Egilman D. S., Krumholz H. M. The ADVANTAGE seeding trial: A review of internal documents
// Annals of Internal Medicine. 2008. Vol. 149. № 4. P. 251–258.Krimsky S., Rothenberg L. S., Stott P., Kyle G. Scientific journals and their authors’ financial interests: A pilot study
// Psychotherapy and psychosomatics. 1998. July-October. Vol. 67. № 4–5. P. 194–201.Papanikolaou G. N., Baltogianni M. S., Contopoulos-Ioannidis D. G. et al. Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions
// BMC medical research methodology. 2001. Vol. P. 3.Sismondo S. Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?
// PLoS Medicine. 2007. Vol. 4. № 9, e286.Mirowski P., Van Horn R. The contract research organization and the commercialization of scientific research
// Social studies of science. 2005. August. Vol. 35. № 4. P. 503–548.Gubler A. Alternating hemiplegia, a sign of pontine lesion, and documentation of the proof of the facial decussation
/ Wolf J. K. (ed.). The Classical Brainstem Syndromes. Springfield: Charles C Thomas, 1971. P. 9–13.Austin S. C., Stolley P. D., Lasky T. The history of malariotherapy for neurosyphilis
// JAMA. 1992. Vol. 268. № 4. P. 516–519.Valenstein E. S. Great and desparate cures: The rise and decline of psychosurgery and other radical treatments for mental illness
. New York: Basic Books, 1986.EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial
// The New England journal of medicine. 1985. November 7. Vol. 313. № 19. P. 1191–1200.